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Gene regulation is an important fundamental biological process. The regulation of gene ex-
pression is managed through a variety of methods including epigentic processes (e.g., DNA
methylation). Understanding the role of epigenetic changes in gene expression is a funda-
mental question of molecular biology. Predictions of gene expression values from epigenetic
data have tremendous research and clinical potential. Dynamical systems can be used to
generate a model to predict gene expression using epigenetic data and a gene regulatory
network (GRN). Here we present a novel stochastic dynamical systems model that predicts
gene expression levels from methylation data of genes in a given GRN.
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21. Introduction
Gene regulation is an important fundamental biological process. It involves a number of
complex sub-processes that are essential for development and adaptation to the environment
(e.g., cell differentiation1 and response to trauma2). Understanding gene expression patterns
has broad scientific3 and clinical4 potential, including providing insight into patterns of funda-
mental molecular biology (e.g., gene regulatory networks) and a patient’s response to disease
(e.g., HIV infection5) or treatment (e.g., chemotherapy-induced peripheral neuropathy6).
The regulation of gene expression is managed through a variety of methods, including
transcription, post-transcriptional modifications, and epigenetic processes.7 One epigenetic
process, DNA methylation,8 occurs primarily at the cytosine base of the molecule that is
adjacent to guanine (i.e., CpG site). DNA methylation of promoter and gene body regions
can act to regulate gene expression by repressing (e.g.,9) or activating (e.g.,10) transcription.
Understanding the role of epigenetic changes in gene expression is a fundamental question
of molecular biology and predicting gene expression from epigenetic data is an active area of
research. Predictions of gene expression values from epigenetic data have tremendous research
and clinical potential. For example, DNA is inexpensive to collect and is easy to store. It offers
both genetic (i.e., genotype) and epigenetic (i.e., methylation status) information in a stable
format. This information is obtainable from a large number of ongoing and previously existing
biobanks. Gene expression (i.e., RNA), however, is more difficult and more expensive to obtain.
Given the unique type of information that gene expression can provide (i.e., the presence and
quantity of the functional product of a gene), it will be very useful and economical if gene
expression values could be reliably predicted from methylation information.
A dynamical systems model can predict gene expression using epigenetic data and a gene
regulatory network (GRN) by simulating hypothesized mechanisms of transcriptional regu-
lation. Such models provide predictions based directly on these biological hypotheses. We
develop an interaction network model11 that depends on epigenetic changes in a GRN.
One major advantage to the dynamical systems approach is obtaining a distribution of
gene expression beyond just expression status. Furthermore, a stochastic dynamical system
provides us with a distribution of gene expression estimates, representing the possibilities that
may occur within the cell.
Recent studies have developed models to predict gene expression levels with deep con-
volutional neural networks12 from genome sequence data and with regression models from
methylation data.13 Previous studies have developed models to predict expression status (e.g.,
on/off or high.low) with gradient boosting classifiers from histone modification data,14 and
with machine learning classification methods from methylation data15 and from methylation
and histone data combined.16 To our knowledge, there are no studies that have taken a dy-
namical systems approach to predicting gene expression from methylation data and a GRN.
Given the opportunity presented by dynamical systems approaches and the potential prac-
tical utility, we present a novel stochastic dynamical systems model for predicting gene ex-
pression levels from epigenetic data for a given GRN.
32. Methods
2.1. Assumptions
Our model assumes fundamentally that transcription of DNA is (relatively) fast and done
at a linear rate determined by the bound or unbound state of transcription factor binding
sites. We assume that binding and unbinding of transcription factors is a (relatively) slow
and stochastic process, with propensity proportional to availability of transcription factor.
Our model is built on the hypothesis that the propensity of transcription factor binding
is influenced non-linearly by epigenetic modification of the binding site. We assume that
“background” transcription (i.e. transcription occurring when no transcription factor is bound)
is only enough to allow down regulation to exist. In model training and testing, genes with
missing expression data are assigned ’zero’ expression values.
2.2. Model Equations
We model gene regulation using a piecewise-deterministic Markov process (PDMP) as
introduced in Davis 198417 (see also18,19) given by the equations:
Bi(t) = Bi(0) + Y
i
1
(∫ t
0
(1−Bi(τ))λi µi
µi + (αi)νi
(κi · g)dτ
)
− Y i2
(∫ t
0
λˆiBi(τ)dτ
)
(1)
and
d
dt
gj = γj + (φj ·B)− djgj (2)
where Bi(t) ∈ {0, 1}, is a boolean random variable representing the bound/unbound state of
a binding site region of DNA and gi is the transcript amount the genes modeled. Equation (1)
is given as the sum of two Poisson jump processes Y i1 (h
i
1(t)) and Y2(h
i
2(t)) which take values in
Z≥0, and are piecewise constant between randomly spaced discrete time points (the binding
and unbinding events).20
The propensities hi1(t) and h
i
2(t) are taken to be linear functions of the available tran-
scription factors, which is assumed to be the same as the transcript variables gj. We take the
values κij ∈ {0, 1}; these parameters along with the set of φji represent the structure of the
underlying gene regulatory network.
We include the term
µi
µi + (αi)νi
(3)
to represent the impact of epigenetic modification on the binding propensity of transcription
factors. In this term, αi is the measured epigenetic modification to a transcription factor
binding site (e.g. percentage of methylated bases). Equation (3) is a sigmoidal function which
is either strictly increasing or strictly decreasing depending on the sign of νi. If νi > 0, then this
term decreases, implying that epigenetic modification decreases transcription factor binding.
Conversely, if νi < 0, the model implies that epigenetic modification increases transcription
factor binding.
Finally, we use a linear ODE for the value of the transcripts gj. We take φji ∈ {−1, 0, 1}
based on the structure of the underlying gene regulatory network. We include baseline tran-
scription γj and decay dj. Because we use a linear ODE in Eq. (2), we can solve exactly
between jumps of B.
42.3. Master Equation and Equilibrium Distribution
It is common practice in the study of reaction networks modeled as stochastic jump pro-
cesseDetail of figure 9 in manuscript.s to represent the process using so called “chemical
master equation”,21,22 which is the Kolmogorov forward equation for the jump process. The
generator for a PDMP can be defined (see Aza¨ıs 201423 for details). We define a density
P (Bi, g(t), t) = P i(g), i = 1, ..., |B| for each possible state Bi of B such that ∑|B|i=1 P i(g) = P (g)
is the probability distribution for the vector g, and each Pi satisfies
dP i(g, t)
dt
=
|g|∑
j=1
(
γj + (φj ·Bi)− djgj
) ∂P i(g, t)
∂gj
+
∑
(j:‖Bj−Bi‖1=1)
|B|∑
k=1
[
Bik(1−Bjk)λk
µk
µk + (αk)νk
(κk · g) + λˆkBjk(1−Bik)
]
P j(g, t)
−
|B|∑
k=1
[
(1−Bik)λk
µk
µk + (αk)νk
(κk · g) + λˆkBik
]
P i(g, t). (4)
2.4. Model Sampling & Equilibrium Distribution Estimation
We can estimate the equilibrium distribution for the PDMP using kernel density estimation
(KDE) with a Gaussian kernel. To compute the marginal distributions on the various gene
variables, which we can estimate with a 1 dimensional kernel. In a realization of the process,
binding or unbinding events occur at times ti such that [t0, t1)unionsq [t1, t2)unionsq · · · unionsq [tn−1, T ) = [t0, T )
and we may compute g(t) exactly in each interval. The estimation is then
fi(x) =
n−1∑
k=0
∫ tk+1
tk
1√
2pih
exp
(
−
(
x− [e−di(t−tk)(gi(tk)− Ski ) + Ski ])2
2h2
)
dt (5)
where Ski =
1
di
(γi +
∑
j φijBj). In Fig. 1, we show schematically how fi(x) is estimated from a
realization of the process B(t), g(t).
For each binding site i
αli κi
λi λˆi µi νi
Bi(t)
For each gene j
φj
dj γj
gj(t)
f lj(x) =
∫ Tl
0
Kj(gj(t), x)dt
For each data point l
Fig. 1. Plate diagram of the process to estimate the marginal PDF fj(x) of each gene’s transcript level according to our model.
Parameters in diamonds are read from data, parameters in hexagons are determined by the structure of the network, parameters
in circles must be fit to the model by maximizing likelihood over a training data set, and parameters in stars are the state variables
of the dynamical model. Notice that the dynamical model implies that the state variables depend on each other, meaning this
network of dependence is not acyclic. The kernel Kj(x, y) used to estimate likelihood is Gaussian kernel in only component j
(i.e., it is the Guassian kernel after orthogonal projection onto dimension j).
52.5. Model Parameter Estimation
While the parameters κij , φji and γj are determined by the structure of the underlying gene
regulatory network, assumed to be known, and the epigenetic parameter αi is assumed mea-
surable, we must still estimate the remaining parameters λi, λˆi, µi, νi and dj. We estimate these
parameters using a negative log-likelihood minimization procedure using stochastic gradient
descent. Sample paths used to estimate the gradient of the likelihood are generated using a
modified form of Gillespies algorithm which handles time-dependent jump propensities.24 This
procedure involves approximating the gradient of the map from parameter set to log-likelihood
so that we can use a gradient descent method. In Fig. 2, we give a schematic representation
of how LˆD is estimated from a set of realizations of the model, each realization corresponding
to a single data sample.
For each binding site i
αli κi
λi λˆi µi νi
Bi(t)
For each gene j
φj
dj γjglj
gj(t)
Ll =
1
Tl
∫ Tl
0
K(g(t), gl)dt
For each data point l
LˆD = −
∑|DataSet|
l=1 ln(Ll)
Fig. 2. Plate diagram of the process to estimate total likelihood of a data set according to our model. Parameters in diamonds
are read from data, parameters in hexagons are determined by the structure of the network, parameters in circles must be fit to
the model by maximizing likelihood over a training data set, and parameters in stars are the state variables of the dynamical
model. Notice that the dynamical model implies that the stat variables depend on each other, meaning this network of dependence
is not acyclic. The kernel K(x, y) used to estimate likelihood is Gaussian.
2.5.1. Gradient Estimation
In order to estimate ∇LˆD,ω for use in optimization, we can use the generator of the system.
To do this, we must rewrite the likelihood estimate Lg,α(θ) as a sum of partial likelihoods Lig,α
defined for each possible state of the vector B. Then, because we are estimating the likelihood
at an equilibrium distribution, we may use Eq. (4) and assume that dP
i
dt = 0 to compute each
∇Lig,α. See supplemental file for a derivation of ∇Lig,α using this method.
2.6. Creation of model from known GRN
We use a gene regulatory network assumed to be known to create a model of
gene regulation that includes transcription factor binding dynamics. To do this, we as-
sociate binding sites with the genes that they regulate, and use these associations to
create a bipartite graph. Due to the available level of detail in the data set, we
rely only on associations between binding sites and targets. We therefore assume that
any regulator of a given target binds with every site associated with that target.
6g1 g2
g3
g1 g2
g3
B1(x)
B2(x)
B3(x)
B4(x) B1(y)
B4(y)
Fig. 3. (left) Underlying gene regulatory network. (right) Bipartite network
of the underlying GRN.
In order to capture the effects
of different regulating transcrip-
tion factors that may bind to
the same site, we create “du-
plicate” variables that represent
the same binding site but bound
with different transcription fac-
tors. The result is that we have
only one transcription factor for
each binding site variable. As
shown in Fig. 3, each edge of
a graph representing the original
gene regulatory network is replaced by a path from transcription factor to binding site to tar-
get gene. Note that the model as described in Section 2.2 allows a more general topology, and
our procedures for parameter fitting and model analysis do not depend on this construction.
3. Model Evaluation
3.1. Gene Regulatory Network
Gene to gene interactions (κ) were defined using the Discriminant Regulon Expression
Analysis (DoRothEA) framework.25 Transcription factor (TF) to target interactions were de-
fined using the DoRothEA highest confidence interactions and scored are just 1 or -1 for up-
regulating and downregulating, respectively. Binding site to target edges (φ) were defined by
CpG methylation sites which were associated with changes in transcript expression (eCpG).26
eCpG probes were identified for genes with which a change in expression was associated with
a change in methylation state in participants from the Multi-Ethnic Study of Atherosclerosis
(MESA). These CpG probes were then classified into a status which described the geographic
relationship between CpG probe and the associated gene (e.g., “TRANS”, “Promoter”, “TSS”,
“Distal”). The binding site regions used in this study for a gene were defined by the proximal
status classifications of the MESA data (i.e., ‘Promoter’ or ‘TSS’) and were scored as the mean
of all of CpG probes in the status class. For evaluation, we identified a set of genes previously
identified as deferentially expressed in individuals with PTSD as compared to controls.27 Of
these, we identified 278 regulator to target maps (kappa) which we then used to identify other
targets to include. The final set included 512 gene to gene relationships comprised of 303
unique target genes. A GRN was built using these 303 genes as input producing a final net-
work with 74 genes with 65 sites (network shown in supplemental file). Of these 74 genes, 29
had sufficient regulatory information (i.e., an associated binding site and transcription factor)
for which parameters could be estimated and expression distributions generated.
3.2. Model Training and Testing Data
Matched epigenetic and gene expression data were obtained from the Grady Trauma
Project (GTP) study. Methylation and gene expression was measured from whole blood from
African American participants. Methylation data were obtained from the NCBI Gene Expres-
sion Omnibus (GEO) (GSE72680) and measured using the Illumina HumanMethylation450
7BeadChip. Methylation status was quantified as a beta score. A total of 19,258 eCpG probes
were used as input. Beta scores for CpG sites within the same region for a gene (i.e., ‘Promoter’
or ‘TSS’) were aggregated together as the average. Probes were merged in 1,885 regions. Re-
gions that were not detected in any sample (i.e., “NaN”) were removed. Gene expression data
were obtained from GEO (GSE58137) measured with the Illumina HumanHT-12 expression
beadchip. Two batches of non-overlaping samples were quantified using two versions of the
beadchip (V3.0: n=243 participants, mean expression intensity = 189.96, IQR = 49.88 to
106.60; V4: n=106 participants, mean expression intensity = 321.58, IQR = 88.85 to 139.78).
Intensity scores were log2-transformed. Gene expression probes were first annotated to EN-
TREZ ID and then annotated to the symbol using the HUGO annotation.28 Genes with
multiple gene expression measurements (i.e., multiple probes) were represented by the last
one in the list when processed. The final merged datasets contained n=243 samples for the
participants measured for expression on the V3.0 beadchip and n=97 for the participants
measured for expression on the v4.0 beadchip.
Fig. 4. The mean and variance over time for simulation of gene AK3 for sample 5881.
Fig. 5. Negative log-likelihood estimate of training data set for
split 99x at each iteration of maximum-likelihood gradient de-
scent procedure.
Matched data from participants mea-
sured for expression on the v3.0 beadchip
(n=243) were used for evaluation. This
primary dataset was split into training
and testing datasets, containing 80%/20%
(n=195, n=48 samples, respectively). To
avoid the impact of a particular split, we
repeated the shuffle process 100 times. For
each split of the data, parameter estima-
tion was performed on the training set and
equilibrium distributions of the predicted
expression levels were generated using the
testing set. We evaluated the performance
of the method as the difference between the
measured and predicted value for each gene.
83.3. Estimation of equilibrium distribution
Fig. 6. Equilibrium distribution plots for CCM2 for individual (a) 6110 in shuffle 43, and (b) 6742 in shuffle 77.
Table 1. Average root mean square errors for each
gene across the 100 shuffles with fitted parameters
and random parameters.
Gene
Symbol
Average
RMSE
fitted
parameters
Average
RMSE
random
parameters
Difference Relative
performance
AHR 2.196 6.113 3.918 2.785
AK3 0.757 10.459 9.702 13.810
ALOX5 2.172 6.797 4.625 3.129
BAG3 1.276 7.251 5.976 5.685
BAK1 1.637 8.114 6.478 4.958
CCM2 0.876 10.842 9.966 12.377
CD19 0.925 9.389 8.464 10.148
CD4 1.232 8.982 7.750 7.290
CTSH 1.262 8.278 7.016 6.561
CXCR5 4.425 7.444 3.020 1.683
CYP27A1 0.886 8.535 7.650 9.636
FBXO32 1.163 8.939 7.777 7.689
FCER1A 1.536 9.926 8.391 6.463
GSTM1 0.792 11.160 10.369 14.101
ICAM4 2.101 7.583 5.482 3.609
IRF1 3.357 10.636 7.280 3.168
LDHA 2.693 10.870 8.178 4.037
LTA4H 3.193 11.846 8.653 3.710
MT1X 1.222 9.468 8.247 7.749
NR1D2 0.932 7.585 6.654 8.142
OAS1 1.162 9.794 8.633 8.431
RPL39L 1.211 7.995 6.785 6.602
RRM2B 1.085 7.658 6.573 7.057
SCP2 4.598 7.354 2.757 1.600
SLC20A1 1.877 10.684 8.807 5.691
SREBF1 1.784 6.582 4.799 3.691
SURF6 1.107 9.236 8.130 8.347
VWA5A 2.744 7.310 4.567 2.664
ZNF654 3.254 8.015 4.762 2.464
In order to conserve computational resources,
we used as a stopping condition for sample path
simulation the number of random numbers that
were needed for simulation to some time point.
This was number was set to 2000 random draws.
To evaluate if the gradient descent process was be-
ing ended too early, one additional shuffle was per-
formed (”99x”) which used an existing shuffle (”99”)
but with parameters allowing for less constrictive
stopping conditions maxsteps=10000 StoppingCon-
dition=100. While simulating, we saved mean and
variance estimates for the distribution for interme-
diate time-points in order to approximate the rate
of convergence to an equilibrium distribution. We
use a finite difference estimate for the rate of change
of estimated mean and variance to determine if the
stopping condition that we used is appropriate. We
can see from Fig. 4 that longer simulation time may
be necessary for accurate estimates of equilibrium.
3.4. Performance evaluation
To evaluate the performance of our fitting procedure on gene expression predictions we
generated predictions using a randomly generated parameter set. To avoid the impact of
a particular split, we randomly generated parameters for each of the previously generated
splits (i.e., the 100 splits previously used for training and testing). Ten random estimates
were generated for each shuffle giving 1000 predictions for each gene generated using random
parameters. We evaluated the performance of the parameter fitting method as the ratio of
root-mean-square error of the predicted value given by randomly chosen and fitted parameters:
Relative performance =
Average RMSE(random parameters)
Average RMSE(fitted parameters)
.
94. Results
Fig. 7. Equilibrium distribution plots generated from random parameters for AK3 for individual (a) 6522 for random parameter
set 0 in shuffle 0, and (b) 8331 random parameter set 7 in shuffle 13.
4.0.1. Estimated parameters
Fig. 8. (Top) Predicted versus ob-
served expression values and (Bottom)
residuals for the test samples for all 100
shuffles for AK3. Each shuffle is col-
ored.
Parameters were estimated for all genes using the proce-
dure detailed in Section 2.5. Figure 5 shows the likelihood of
the training dataset during the course of the gradient descent
procedure.
4.0.2. Equilibrium distributions
Equilibrium distributions were generated for 29 genes for
which we had sufficient connectivity information available.
Example equilibrium distributions for the CCM2 gene for two
samples from different shuffles are shown in Fig. 6. Average
root mean square errors for each gene across the 100 shuffles is
reported in Table 1. We observed the highest performance for
AK3 (average RSME = 0.757, Fig. 8) and lowest for SCP2
(average RSME = 4.598). In this evaluation, our model bi-
ases towards underestimating the expression levels (see sup-
plemental file). Relative to a random set of parameters, our
fitted parameters improved the predictions by a factor of 1.6
to over 14 (Table 1). For example, the predicted expression
distribution for AK3 generated from random parameters are
show in Fig. 9 and the predicted versus observed values are
shown in Fig. 7.
5. Discussion
In this study, we demonstrate that gene expression levels
can be accurately predicted from methylation state of a pro-
moter region and a GRN. Our model successfully uses quantitative data describing epigenetic
modification of transcription factor binding sites to generate a probability distribution which
describes the possible level of transcript. To our knowledge, this is the first study to develop
and evaluate a stochastic dynamical systems model predicting gene expression levels from
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epigenetic data for a given GRN.
By using a dynamical systems approach, our model generates an estimation of gene ex-
pression given DNA methylation based on the mechanistic hypothesis of differential binding
affinity of a transcription factor caused by epigenetic modification. Furthermore, the dynam-
ical systems approach allows study of complex regulatory networks, including those which
contains cycles. This method has the potential for broad practical usage. DNA is broadly
available in banked tissue in the absence of RNA. By measuring methylation from these spec-
imens, RNA expression value can be estimated. In addition to predicting RNA expression
from specimens, our model can also be used to evaluate for functional effects of changes in
methylation states at particular sites on gene expression levels.
Fig. 9. (Top) Predicted versus ob-
served expression values and (Bottom)
residuals for the test set generated from
10 sets of random parameters for all
100 shuffles for AK3. Each shuffle and
parameter set is colored.
Overall we see good performance in the predictions of the
model with fitted parameters (e.g., Fig. 8) and dramatic im-
provements to prediction relative to a randomly generated
set of parameters (e.g., Fig. 9). Although the predictions are
somewhat dependent on the selection of training data, and in
some cases, the observed value and predicted value are not
well represented by the equilibrium distribution the overall
prediction of the occurrence of gene expression remains accu-
rate (i.e., on/off or low/high). Poor predictions could be the
result of slow convergence in the maximum-likelihood param-
eter estimation. In order to estimate parameters, we must it-
eratively generate model predictions for a range of parameter
values. This is done by generating equilibrium distributions
in a method similar to Markov-Chain Monte Carlo (MCMC)
sampling.
The estimated fit of the model to training data improved
over iterations of the procedure (e.g., Fig. 5). However, the
mean and standard deviations from the equilibrium distribu-
tions do not converge as quickly as we would like (e.g., Fig. 4).
This slow convergence, and the necessity for repeated esti-
mations, mean that computational time is a limiting factor.
Future analyses should simulate longer to identify the appro-
priate cut offs given the data used, and thus improve the fit
of the model parameters.
We were able to accurately predict gene expression despite
the limited size of our GRN. We expect that model predic-
tions will improve with more regulatory information. Although we queried for 302 genes, our
transcription factor to target and binding site reference data produced a gene regulatory net-
work with 74 genes, of which 29 had sufficient regulatory information to be predicted. In
particular, dynamical systems should perform well in gene regulatory networks with complex
topologies, including those with loops. We were unable to evaluate a more complicated GRN
from all reference regulatory data due to computational constraints. As such, we evaluated
11
with the toy model of PTSD data which was acyclic.
While the use of a stochastic dynamical system has distinct advantages over more
statistically-driven methods, there are of course limitations to the approach as well. In partic-
ular, our model is based on the assumption that epigenetic modification effects the propen-
sity of the random process of transcription factor binding and unbinding. Furthermore, our
model assumes that DNA transcription is a comparatively fast (and so approximated as deter-
ministic) process that depends on transcription factor binding. Finally, our model implicitly
assumes that RNA translation to protein product is immediate. In addition to the funda-
mental limitations of the model, we also limit the scope of our testing to linear production
of DNA transcript, depending on transcription factor binding status. Future efforts will be
focused on improving the prediction accuracy, improving prediction robustness across folds,
and evaluating across other gene regulatory networks and gene sets.
In conclusion, we have developed a dynamical systems approach which accurately predicts
gene expression from methylation state and a GRN. Our results support the idea that methy-
lation patterns of cis-promoter regions are associated with gene expression levels. Advances in
gene regulatory information will continue to improve the predictions of our model by providing
more structure to the GRNs. In addition, we have a route forward to develop optimizations
which can step up the ease of use and scaling of our approach. Finally, our approach is broadly
accessible and can be used for a diverse array of research projects which have DNA samples
available but in which gene expression data are missing or limited or in studies evaluating the
functional effects of changes in methylation state on gene expression.
6. Code availability
Supplemental files, including further mathematical details, are available at https://
doi.org/10.5281/zenodo.3970970. All code are available at https://github.com/kordk/
stoch_epi_lib.
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